During the development of NASH, the NRF2-mediated antioxidant system is unable to adequately limit the ROS overload stimulated by PDGF and TGF-β1 (secreted by KCs and HSCs). Here, NFE2L2 is linked to metabolic dysfunction-associated steatohepatitis.